La Trobe
1175427_Acosta,J_2021.pdf (1.16 MB)

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Download (1.16 MB)
journal contribution
posted on 2021-10-01, 03:32 authored by M Ruscica, PE Penson, N Ferri, CR Sirtori, M Pirro, GBJ Mancini, N Sattar, PP Toth, A Sahebkar, CJ Lavie, ND Wong, M Banach, J Acosta, M Al-Khnifsawi, F Alnouri, F Amar, AG Atanasov, G Bajraktari, S Bhaskar, B Bjelakovic, E Bruckert, R Ceska, AFG Cicero, X Collet, O Descamps, D Djuric, R Durst, MV Ezhov, Z Fras, D Gaita, AV Hernandez, SR Jones, J Jozwiak, N Kakauridze, A Kallel, N Katsiki, A Khera, K Kostner, R Kubilius, G Latkovskis, AD Marais, SS Martin, JA Martinez, M Mazidi, DP Mikhailidis, E Mirrakhimov, AR Miserez, O Mitchenko, NP Mitkovskaya, PM Moriarty, SM Nabavi, D Nair, Demosthenes Panagiotakos, G Paragh, D Pella, Z Petrulioniene, A Postadzhiyan, R Puri, A Reda, Ž Reiner, D Radenkovic, M Rakowski, J Riadh, D Richter, M Rizzo, MC Serban, AMA Shehab, AB Shek, C Stefanutti, T Tomasik, M Viigimaa, P Valdivielso, D Vinereanu, B Vohnout, S von Haehling, M Vrablik, HI Yeh, J Zhisheng, A Zirlik
Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic inflammation that have led to a significant reduction in cardiovascular disease (CVD) risk. Although the use of nutraceuticals to prevent CVD has largely focused on lipid-lowering (e.g, red-yeast rice and omega-3 fatty acids), there is growing interest and need, especially now in the time of coronavirus pandemic, in the use of nutraceuticals to reduce inflammatory markers, and potentially the inflammatory CVD burden, however, there is still not enough evidence to confirm this. Indeed, diet is an important lifestyle determinant of health and can influence both systemic and vascular inflammation, to varying extents, according to the individual nutraceutical constituents. Thus, the aim of this Position Paper is to provide the first attempt at recommendations on the use of nutraceuticals with effective anti-inflammatory properties.


Publication Date



Progress in Cardiovascular Diseases




13p. (p. 40-52)





Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.

Usage metrics

    Journal Articles


    No categories selected


    Ref. manager